Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib

Viola Denzinger, Kristina Busygina, Janina Jamasbi, Isabell Pekrul, Michael Spannagl, Christian Weber, Reinhard Lorenz, Wolfgang Siess*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)397-406
Number of pages10
JournalThrombosis and Haemostasis
Volume119
Issue number3
DOIs
Publication statusPublished - Mar 2019

Keywords

  • Btk inhibitor
  • platelet aggregation
  • bleeding
  • PFA
  • GPVI
  • TYROSINE KINASE INHIBITOR
  • GLYCOPROTEIN VI BINDS
  • TERM-FOLLOW-UP
  • THROMBUS FORMATION
  • TARGETING BTK
  • ACTIVATION
  • AGGREGATION
  • COLLAGEN
  • SINGLE
  • PLAQUE

Cite this